Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort
Article Details
-
Date Published
May 21, 2026
Mast AS, Lang P, Schlegel P, Calkoen FG, Atar D, Scheuermann S, Klein S, Braun C, Schinle F, Schmidt M, Hensen L, Ebinger M, Doring M, Schafer JF, Schulte J, Bethge WA, Lengerke C, Alahmari B, Hu P, Schneider D, Orentas RJ, Handgretinger R, Seitz CM. Human CART22.19 therapy in refractory pediatric B-ALL: insights from a named-patient cohort. J Immunother Cancer. 2026 May 21. 14doi:10.1136/jitc-2025-013901. PMID: 42167809